How worried should investors be about the renminbi? In this edition of our China on-site series we give our take on China’s currency and also discuss the increasing accessibility to China’s vast onshore equity market.
Although currently concerns have abated, every now and then investor worries crop up about the renminbi. We have confidence, however, that China has its currency under control.
Over the last few years, the Chinese government has undertaken an extensive process to liberalize and internationalize the renminbi, which is now the sixth most used currency in world trade.
The main reason for investors to get nervous, is the prospect of a weakening renminbi, causing Chinese investors to lose confidence in the national currency and looking for ways to invest their money outside of China, triggering a downward spiral.
However, we see the People’s Bank of China (PBOC) managing this risk carefully. Since late 2015, it manages the currency against a basket of currencies (China Foreign Exchange Trade System or CFETS), and no longer versus the USD alone. Capital controls mean that only limited amounts of money can leave the country. Stepped up measures worked well in early 2017, for example, when investors were nervous because of shrinking Chinese reserves. The PBOC intervened by strengthening its capital controls, causing the renminbi to stabilize and markets to relax. Figure 1 shows that the renminbi has been quite stable of late.
Of course, renminbi worries may re-appear, which can have a short-term impact on market sentiment and is an important issue to watch. Longer term, however, we have confidence in the PBOC’s ability to safeguard the currency’s stability.
Chinese A-shares, trading on two exchanges in Shanghai and Shenzhen, are becoming increasingly important. As the A-share market is opening up to investors and MSCI plans to include A-shares this year, a lot of capital is expected to flow into the onshore Chinese market.
A-shares offer investors access to themes that are less well represented in the offshore universe. Some sectors that make up the ‘new economy’, like healthcare, mass market consumer products, services and technology, are showing better growth than the market as a whole. They account for about 40% of total A-share market capitalization. The market also offers exposure to state-owned enterprises, which we expect to make significant progress in terms of mixed ownership and corporate governance.
The A-share market offers broad exposure to China, and is currently still lowly correlated with the offshore Chinese market, and other global equity markets.
The vast A-share market, which makes up over 70% of the Chinese market, is increasingly opening up to foreign investors. At the start in 1990, only domestic investors could purchase A-shares. From 2002, foreign institutional investors that met strict conditions were granted access in the shape of quotas. In 2014, the Shanghai-Hong Kong and in 2016, the Shenzhen-Hong Kong Stock Connect schemes were launched, providing further access. They allowed investors to easily trade shares on the other markets using their local brokers and clearing houses.
In June, MSCI is to include Chinese A-shares in the MSCI Emerging Markets Index, starting with a 5% inclusion factor. This is an important step, as we expect it to support the renminbi and improve the A-share market’s investor structure from retail-dominated to a more balanced mix of institutional and retail investors. Furthermore, we expect the inclusion to improve China’s capital market liberalization and regulation. Full inclusion will take five to ten years, depending on progress in market accessibility.
Major new themes, such as the consumption upgrade due to China’s growing middle class, the Made in China 2025 initiative to become a quality producer, and China’s leadership in technology and innovation, are creating many investment opportunities. The Chinese A-share market is a good place to gain access to them.
In the next edition: trade wars and opportunities in the healthcare sector.
The information contained on these pages is for marketing purposes and solely intended for Qualified Investors in accordance with the Swiss Collective Investment Schemes Act of 23 June 2006 (“CISA”) domiciled in Switzerland, Professional Clients in accordance with Annex II of the Markets in Financial Instruments Directive II (“MiFID II”) domiciled in the European Union und European Economic Area with a license to distribute / promote financial instruments in such capacity or herewith requesting respective information on products and services in their capacity as Professional Clients.
The Funds are domiciled in Luxembourg and The Netherlands. ACOLIN Fund Services AG, postal address: Affolternstrasse 56, 8050 Zürich, acts as the Swiss representative of the Fund(s). UBS Switzerland AG, Bahnhofstrasse 45, 8001 Zurich, postal address: Europastrasse 2, P.O. Box, CH-8152 Opfikon, acts as the Swiss paying agent. The prospectus, the Key Investor Information Documents (KIIDs), the articles of association, the annual and semi-annual reports of the Fund(s) may be obtained, on simple request and free of charge, at the office of the Swiss representative ACOLIN Fund Services AG. The prospectuses are also available via the website www.robeco.ch. Some funds about which information is shown on these pages may fall outside the scope of the Swiss Collective Investment Schemes Act of 26 June 2006 (“CISA”) and therefore do not (need to) have a license from or registration with the Swiss Financial Market Supervisory Authority (FINMA).
Some funds about which information is shown on this website may not be available in your domicile country. Please check the registration status in your respective domicile country. To view the RobecoSwitzerland Ltd. products that are registered/available in your country, please go to the respective Fund Selector, which can be found on this website and select your country of domicile.
Neither information nor any opinion expressed on this website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco Switzerland Ltd. product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports.